Trade Summary

4 days ago, Guyer William, serving as Chief Development Officer at Corcept Therapeutics Inc (CORT), sold 20,000 shares at $51.83 per share, for a total transaction value of $1,036,600.00. Following this transaction, Guyer William now holds 2,231 shares of CORT.

This sale represents a 90.00% decrease in Guyer William's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 5, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 7, 2026, 2 days after the trade was made.

Corcept Therapeutics Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.